The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising development. Unlike injections, this technique offers a less invasive way to administer GLP-1 https://myamkbh996362.blogaritma.com/38883464/glp-1-patches-a-new-approach-to-blood-sugar-treatment